Fluorouracil and Dose-Dense Chemotherapy in Adjuvant Treatment of Patient with Early-Stage Breast Cancer: an Open-Label, 2 x 2 Factorial, Randomised Phase III Trial

被引：0
|
作者：
Colle, E. [1 ]
Besse, B. [2 ]
机构：
[1] AERIO, Paris, France
[2] Gustave Roussy, F-94800 Villejuif, France
来源：
ONCOLOGIE | 2015年 / 17卷 / 7-8期
关键词：
METAANALYSIS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：330 / 332
页数：3
相关论文
共 50 条
  • [31] Chemotherapy dose delays and dose reductions in breast cancer patients receiving dose-dense FEC and docetaxel -: results of a randomized, open-label phase II study
    Wildiers, H.
    Dirix, L.
    Neven, P.
    Prove, A.
    Clement, P.
    Amant, F.
    Skacel, T.
    Paridaens, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S150 - S150
  • [32] Adjuvant treatment of early-stage breast cancer with eribulin mesylate following dose-dense doxorubicin and cyclophosphamide: preliminary results from a phase 2, single-arm feasibility study
    Traina, T. A.
    Hudis, C.
    Fornier, M.
    Lake, D.
    Lehman, R.
    Berkowitz, A. P.
    Rege, J.
    Liao, J.
    Cox, D.
    Seidman, A. D.
    CANCER RESEARCH, 2012, 72
  • [33] Tailored dose-dense chemotherapy in combination with trastuzumab as adjuvant therapy for HER2-positive breast cancer: A secondary analysis of the phase III PANTHER trial.
    Foukakis, Theodoros
    Papakonstantinou, Antroula
    Matikas, Alexios
    Bengtsson, Nils-Olof
    Malmstrom, Per
    Hedayati, Elham
    Steger, Guenther G.
    Untch, Michael
    Hubbert, Laila
    Johansson, Hemming
    Hellstrom, Mats
    Gnant, Michael
    Loibl, Sibylle
    Greil, Richard
    Moebus, Volker
    Bergh, Jonas C. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
    Hong, Yong Sang
    Nam, Byung-Ho
    Kim, Kyu-pyo
    Kim, Jeong Eun
    Park, Seong Joon
    Park, Young Suk
    Park, Joon Oh
    Kim, Sun Young
    Kim, Tae-You
    Kim, Jee Hyun
    Ahn, Joong Bae
    Lim, Seok-Byung
    Yu, Chang Sik
    Kim, Jin Cheon
    Yun, Seong Hyeon
    Kim, Jong Hoon
    Park, Jin-hong
    Park, Hee Chul
    Jung, Kyung Hae
    Kim, Tae Won
    LANCET ONCOLOGY, 2014, 15 (11): : 1245 - 1253
  • [35] Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial
    Earl, Helena M.
    Hiller, Louise
    Howard, Helen C.
    Dunn, Janet A.
    Young, Jennie
    Bowden, Sarah J.
    McDermaid, Michelle
    Waterhouse, Anna K.
    Wilson, Gregory
    Agrawal, Rajiv
    O'Reilly, Susan
    Bowman, Angela
    Ritchie, Diana M.
    Goodman, Andrew
    Hickish, Tamas
    McAdam, Karen
    Cameron, David
    Dodwell, David
    Rea, Daniel W.
    Caldas, Carlos
    Provenzano, Elena
    Abraham, Jean E.
    Canney, Peter
    Crown, John P.
    Kennedy, M. John
    Coleman, Robert
    Leonard, Robert C.
    Carmichael, James A.
    Wardley, Andrew M.
    Poole, Christopher J.
    LANCET ONCOLOGY, 2017, 18 (06): : 755 - 769
  • [36] Survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer patients in a randomised trial.
    Kummel, S.
    Krocker, J.
    Kohls, A.
    Breitbach, G-P
    Budner, M.
    Keil, E.
    Hinke, A.
    Blohmer, J-U
    Elling, D.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S113 - S113
  • [37] A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph
    Kuemmel, S
    Krocker, J
    Kohls, A
    Budner, M
    Breitbach, GP
    Ruhland, K
    Köhler, U
    Reischauer, B
    Blohmer, JU
    Elling, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 24S - 24S
  • [38] A nonrandomized phase II study of dose-dense paclitaxel and cyclophosphamide (PC) in early-stage breast cancer (EBC)
    Ramaekers, Ryan C.
    Copur, Mehmet Sitki
    Cowan, Kenneth H.
    Mailliard, Mary
    Lyden, Elizabeth
    Razaq, Wajeeha
    Reed, Elizabeth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: A randomised, phase III trial of the Gruppo Italiano Mammella
    Del Mastro, L.
    Mansutti, M.
    Bisagni, G.
    Ponzone, R.
    Durando, A.
    Amaducci, L.
    Cognetti, F.
    Frassoldati, A.
    Michelotti, A.
    Mura, S.
    Urracci, Y.
    Sanna, G.
    Gori, S.
    De Placido, S.
    Garrone, O.
    Barone, C.
    Bighin, C.
    Poggio, F.
    Lambertini, M.
    Bruzzi, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S407 - S408
  • [40] Dose-dense adjuvant chemotherapy in early breast cancer: 15-year results of the phase III Mammella InterGruppo (MIG)-1 study
    Blondeaux, E.
    Cantore, M.
    Michelotti, A.
    Conte, B.
    Benasso, M.
    Bighin, C.
    Lambertini, M.
    Poggio, F.
    Del Mastro, L.
    ANNALS OF ONCOLOGY, 2019, 30
12345